 Medscape | Choice of First-Line Therapy in Follicular Lymphoma Debated - Medscape Medscape The editorial was prompted by the publication of results from a large Italian phase 3 trial, known as FOLL05, which compared 3 chemotherapy regimens: R-CHOP (rituximab with cyclophosphamide, doxorubicin, vincristine, and prednisone); R-CVP (rituximab ... |
